Johnson & Johnson (JNJ)

266.46 -1.58 (-0.59%) USD  |  NYSE  |  Aug 31, 14:32
More

Johnson & Johnson Total Long Term Debt (Quarterly) : 37.34B for June 30, 2026

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for JNJ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 37.34B
March 31, 2026 37.53B
December 31, 2025 40.84B
September 30, 2025 39.41B
June 30, 2025 39.24B
March 31, 2025 38.36B
December 31, 2024 31.85B
September 30, 2024 31.29B
June 30, 2024 31.64B
March 31, 2024 25.08B
December 31, 2023 26.98B
September 30, 2023 26.05B
June 30, 2023 33.90B
March 31, 2023 34.93B
December 31, 2022 27.99B
September 30, 2022 27.60B
June 30, 2022 28.29B
March 31, 2022 28.85B
December 31, 2021 33.12B
September 30, 2021 30.13B
June 30, 2021 30.31B
March 31, 2021 30.26B
December 31, 2020 35.53B
September 30, 2020 32.68B
June 30, 2020 25.06B
Date Value
March 31, 2020 25.39B
December 31, 2019 28.31B
September 30, 2019 27.64B
June 30, 2019 28.45B
March 31, 2019 28.32B
December 31, 2018 30.32B
September 30, 2018 29.48B
June 30, 2018 29.40B
March 31, 2018 29.84B
December 31, 2017 32.17B
September 30, 2017 26.68B
June 30, 2017 27.36B
March 31, 2017 27.02B
December 31, 2016 24.15B
September 30, 2016 23.55B
June 30, 2016 24.54B
March 31, 2016 20.23B
December 31, 2015 14.96B
September 30, 2015 14.07B
June 30, 2015 14.08B
March 31, 2015 14.94B
December 31, 2014 15.13B
September 30, 2014 13.15B
June 30, 2014 13.30B
March 31, 2014 13.34B

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 49.62B
Merck & Co., Inc. 51.08B
Pfizer Inc. 63.10B
Bristol Myers Squibb Co. 44.59B
Liquidia Corp. 182.90M